3557 results for «223»

Filter By

3557 results

Tricuspid TEER intraprocedural guidance

12 Sep 2025 – From PCR Rio Valves 2025

Master the intraprocedural guidance essential for successful Tricuspid Transcatheter Edge-to-Edge Repair (TEER). This session provides comprehensive insights into pre-procedural analysis, gap measurement techniques, and step-by-step intraprocedural monitoring with expert tips and tricks.

Transcatheter tricuspid valve replacement - Where are we in Latin America?

12 Sep 2025 – From PCR Rio Valves 2025

Stay abreast of the latest advances in transcatheter tricuspid valve replacement (TTVR) across Latin America. This session highlights orthotopic implant technologies, patient selection criteria, early clinical outcomes, and discusses future perspectives including training, technology access, and regional clinical impact.

Transcatheter tricuspid valve replacement - Where are we in Latin America?

Management of hostile access for TAVI

11 Sep 2025 – From PCR Rio Valves 2025

Access challenges are among the most critical hurdles in TAVI procedures. This session explores how to identify difficult access routes using pre-procedural CT, and demonstrates practical techniques to safely overcome these obstacles. Through real-life case presentations—including challenging femoral access with a shockwave balloon, carotid access, and...

Management of hostile access for TAVI

Extreme TAVI: bicuspid valves, emergency TAVI, dissections and more

12 Sep 2025 – From PCR Rio Valves 2025

Explore extreme and complex TAVI cases that push procedural limits, including urgent interventions, bicuspid valve sizing, valve-in-valve strategies, and rare complications such as type A dissection and late coronary occlusion. This session shares valuable clinical experiences and lessons from challenging scenarios.

Mitral valve - The role of the echocardiography imager pre and post intervention

11 Sep 2025 – From PCR Rio Valves 2025

This session emphasizes the critical role of echocardiography imaging pre- and post-mitral valve interventions. It includes case-based post-processing with comprehensive transthoracic and transesophageal echocardiography essential for decision-making in mitral TEER, identification and grading of recurrent mitral regurgitation, and evaluations related to mitral annular calcification and valve-in-calcification...

Addressing challenges in the right heart

11 Sep 2025 – From PCR Rio Valves 2025

This session addresses complex challenges associated with right heart conditions, featuring cases such as post-infarction interventricular septal defect with right heart failure, innovative orthotopic options for tricuspid regurgitation, and advanced edge-to-edge repair using the TRICLIP device. Gain insight into therapeutic strategies for managing severe tricuspid insufficiency...

Tricuspid valve - Present and future perspectives: a critical appraisal

12 Sep 2025 – From PCR Rio Valves 2025

Explore the cutting-edge developments and practical insights in tricuspid valve interventions in this comprehensive session. Learn about the current status and patient selection for orthotopic valve implantation, gain expert guidance on intraprocedural monitoring with step-by-step tips, and understand the critical information required for pre, intra, and...

Management of aortic stenosis: what really matters before and after the procedure

11 Sep 2025 – From PCR Rio Valves 2025

Aortic stenosis management is a lifetime strategy, not a one-time procedure. This session covers key decision-making factors, compares surgical and transcatheter options, and provides guidance on post-procedural care. Learn to individualise treatment based on age, anatomy, and risk, and plan interventions with the patient’s long-term trajectory...

Management of aortic stenosis: what really matters before and after the procedure

Structural heart: demanding anatomies, difficult situations and unusual strategies

12 Sep 2025 – From PCR Rio Valves 2025

Navigate complex structural heart interventions through this session focusing on challenging anatomies and innovative procedural strategies. Topics include orthotopic tricuspid valve replacement amidst anatomical and physiological complexities, percutaneous closure of Valsalva sinus fistula, extreme TAVI approaches for pure aortic regurgitation, management of mitral paravalvular leaks with...

Problem-solving in challenging TAVI cases

11 Sep 2025 – From PCR Rio Valves 2025

Explore complex and challenging TAVI cases with expert-led discussions covering redo TAVI procedures, horizontal aorta anatomy, rapid pacing protocols, lithotripsy-assisted interventions for severe calcific stenosis, and management of procedural complications including valve dislodgement.

Advanced TAVI: techniques, timing, and problem-solving

12 Sep 2025 – From PCR Rio Valves 2025

Advance your knowledge in TAVI with this session addressing sophisticated techniques, procedural timing, and problem-solving in complex cases. Explore TAVI applications in rare quadricuspid valve anatomy with pure aortic insufficiency, strategic decision-making between TAVI and PCI, and innovative solutions for managing aortic stenosis in patients with...

Redefining and optimising LAA closure - LIVE Case

11 Sep 2025 – From PCR Rio Valves 2025

Experience a LIVE educational case from University Hospitals Harrington Heart & Vascular Institute demonstrating a minimalist approach to left atrial appendage (LAA) closure. Learn about the use of intracardiac echocardiography, conscious sedation, and local anaesthesia to improve safety and efficiency, along with patient selection, imaging integration,...

Redefining and optimising LAA closure - LIVE Case

The complexity of transcatheter tricuspid valve interventions

11 Sep 2025 – From PCR Rio Valves 2025

Understand the complexities of transcatheter tricuspid valve interventions through diverse case studies addressing challenging clinical scenarios. Learn about therapeutic alternatives including TEER with pacemaker leads, imaging challenges with ICE, transcatheter tricuspid valve replacement with Evoque and LuxValve devices, and straightforward options like TricValve. Gain perspective on...

The complexity of transcatheter tricuspid valve interventions

First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent vs a durable fluoropolymer-based everolimus-eluting stent in patients with CAD: the ANGIOLITE trial

14 Jan 2020

The durable fluoroacrylate polymer-based sirolimus-eluting stent (Angiolite SES) has shown promising preclinical and clinical results regarding inflammatory vascular reaction and neointimal healing. J. Moreu, et al. aimed to compare performance between the Angiolite SES and an everolimus-eluting stent (EES) in patients with coronary artery disease.

Authors :

J. Moreu, R. Moreno-Gómez, A. Pérez de Prado, B. García del Blanco, R. Trillo, E. Pinar, E. Molina, J. Zueco, A. Merchán, J. Francisco Díaz-Fernández, I. Amat
EuroIntervention: the ANGIOLITE trial

Does metallic stent ablation by rotational atherectomy influence on the coronary microcirculation?

09 Jul 2019

An 80-year-old man underwent percutaneous coronary intervention with a bare-metal stent for severe stenosis at proximal left anterior descending coronary artery 13 years ago. In-stent restenosis was treated by a drug-eluting stent 1 year later...

Influence of stent ablation on the coronary microcirculation

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Yohei Ohno

Author

Yohei Ohno
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
Didn’t find what you were looking for?